Cambridge UK – SICM, a high resolution microscopy technique, has been used by a team of researchers to identify a drug that could one day be used to prevent abnormal heart rhythms, or arrhythmia. The study, published in Hepatology[1] this week, was enabled by SICM, which is the result of 7 years of research and […]

Fluidigm Corporation (NASDAQ:FLDM) announced today a collaboration with BD Biosciences, a segment of BD (Becton, Dickinson and Company), to co-host a public seminar series on the isolation and analysis of single cells. Entitled A Powerful Technique for Single-Cell Analysis, the public seminar series will showcase cell isolation using the BD FACSAria ™ III Cell Sorter […]

WESTLAKE VILLAGE, Calif. — Cynvenio Biosystems, Inc., a developer of high performance cell isolation technology for biomedical research and novel cancer diagnostics, today announced that Amit Munshi and Simon Raab, Ph.D. have joined its board of directors. Mr. Munshi, a leading Southern California biopharma executive, is president and CEO of Percivia, LLC ( www.percivia.com ), […]

Sunnyvale, CA — Molecular Devices, LLC, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced that it will offer a range of training courses through Molecular Devices University. These courses help customers with Molecular Devices instruments, software, and reagents through practical to in-depth training by application scientists and […]

CORNING, N.Y. — Corning Incorporated (NYSE: GLW) today announced the availability of the Corning® HYPERStack™ Cell Culture Vessel for high yield cell growth. The HYPERStack vessel features a unique multi-layered design based on Corning’s gas-permeable-film technology and delivers greater than 2.5 times more cells in the same volumetric footprint as current stacked-plate products. The increased […]

PENZBERG, Germany – RNA interference studies are a powerful technology for high-throughput screening. However, endpoint analyses only provide a snapshot of the analyzed cellular phenotype, as it is not possible to measure developmental changes over time. To address this, a research team led by Stefan Wiemann and Ulrich Tschulena in the Division Molecular Genome Analysis […]

Franklin Lakes, NJ – The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that, in accordance with its long-term succession planning, it has elected Vincent A. Forlenza as Chief Executive Officer and President, effective October 1, 2011. Mr. Forlenza will also become a member of […]

ST. LOUIS – Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich® (Nasdaq: SIAL), today announced the expansion of its CompoZr® Oncology Disease Model portfolio with the release of the first in its collection of breast cancer-specific knockout and knockin cell lines for drug discovery and research. These modified epithelial cell […]

PENZBERG, Germany – Cardiotoxicity, which results when drugs adversely affect the heart, explains why roughly one third of new pharmaceuticals are withdrawn from the market and why many compounds fail in late-stage clinical testing. To address this, a research team led by Kyle Kolaja, PhD, in the Department of Early and Investigative Safety, Nonclinical Safety, […]

Penzberg – Regenerative medicine is dependent on advances in tissue engineering, biochemistry and applied bioengineering to develop and produce cells and cell-based products that regenerate or repair damaged and degenerated tissues and organs. A research team led by Dr. Ursula Graf-Hausner from the Institute of Chemistry and Biological Chemistry at Zurich University of Applied Sciences, […]